Cosmo, Glenmark signs distribution and license pacts for Winlevi in Europe, South Africa EP News Bureau Sep 27, 2023 Cassiopea will receive an upfront payment of $5 million, in addition to double-digit regulatory and sales milestones as well as…
US FDA accepts Glenmark’s IND application for GRC 54276 to proceed with Phase 1/2 clinical study for… EP News Bureau Mar 16, 2023 GRC54276 is an orally available, small molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor developed by Glenmark